X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (163) 163
humans (151) 151
hematology (93) 93
multiple myeloma - genetics (76) 76
multiple myeloma (70) 70
abridged index medicus (68) 68
oncology (66) 66
multiple myeloma - pathology (53) 53
female (46) 46
animals (45) 45
multiple myeloma - drug therapy (45) 45
mice (42) 42
male (40) 40
multiple-myeloma (40) 40
article (34) 34
bortezomib (31) 31
middle aged (30) 30
aged (29) 29
multiple myeloma - metabolism (28) 28
translocation, genetic (28) 28
cancer (27) 27
stem-cell transplantation (24) 24
tumor cells, cultured (23) 23
adult (22) 22
prognosis (22) 22
research (22) 22
treatment outcome (22) 22
cell line, tumor (21) 21
disease progression (21) 21
lymphoid neoplasia (21) 21
thalidomide - analogs & derivatives (21) 21
gene expression regulation, neoplastic (20) 20
antineoplastic agents - therapeutic use (19) 19
dexamethasone - administration & dosage (19) 19
multiple myeloma - mortality (19) 19
risk factors (19) 19
aged, 80 and over (18) 18
cell biology (18) 18
genetic aspects (18) 18
multiple myeloma - therapy (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
apoptosis (17) 17
expression (17) 17
gene expression profiling (17) 17
in situ hybridization, fluorescence (17) 17
undetermined significance (17) 17
care and treatment (16) 16
high-dose therapy (16) 16
immunoglobulin heavy chains - genetics (16) 16
monoclonal gammopathy (16) 16
mouse model (16) 16
activation (15) 15
immunology (15) 15
multiple myeloma - immunology (15) 15
thalidomide (15) 15
mice, inbred c57bl (14) 14
multiple myeloma - diagnosis (14) 14
proteins (14) 14
survival (14) 14
thalidomide - administration & dosage (14) 14
therapy (14) 14
cells (13) 13
dexamethasone (13) 13
health aspects (13) 13
lenalidomide (13) 13
molecular sequence data (13) 13
mutation (13) 13
recurrence (13) 13
survival rate (13) 13
clinical trials and observations (12) 12
hemic and lymphatic diseases (12) 12
in-situ hybridization (12) 12
myeloma (12) 12
survival analysis (12) 12
translocations (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
bone-marrow (11) 11
development and progression (11) 11
diagnosis (11) 11
gene (11) 11
lenalidomide plus dexamethasone (11) 11
chromosome aberrations (10) 10
medicine, general & internal (10) 10
medicine, research & experimental (10) 10
mutations (10) 10
thalidomide - therapeutic use (10) 10
transplantation (10) 10
102 (9) 9
abnormalities (9) 9
combination (9) 9
cyclophosphamide - administration & dosage (9) 9
disease-free survival (9) 9
growth-factor receptor-3 (9) 9
internal medicine (9) 9
mice, transgenic (9) 9
models, biological (9) 9
neoplasm staging (9) 9
plasma-cells (9) 9
translocation (9) 9
translocation, genetic - genetics (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 09/2015, Volume 21, Issue 17 Supplement, pp. IA25 - IA25
Journal Article
Science Translational Medicine, ISSN 1946-6234, 2019, Volume 11, Issue 494, p. eaau9087
Osteolytic lesions in multiple myeloma are caused by osteoclast-mediated bone resorption and reduced bone formation. A unique feature of myeloma is a failure... 
Journal Article
Blood cancer journal, ISSN 2044-5385, 11/2018, Volume 8, Issue 12, pp. 116 - 6
The current definition of plasma cell leukemia (PCL)->= 20% circulating plasma cells (CPCs) on peripheral smear and plasma cell count >= 2 x 10(9)/L-may be too... 
SURVIVAL | ONCOLOGY | HEMATOLOGY | Plasma | Leukemia | Multiple myeloma | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 3018 - 3018
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 5489 - 5489
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 10/2012, Volume 122, Issue 10, p. 3456
Journal Article
Cell, ISSN 0092-8674, 2011, Volume 146, Issue 6, pp. 904 - 917
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2013, Volume 88, Issue 4, pp. 360 - 376
Journal Article
Nature, ISSN 0028-0836, 02/2011, Volume 470, Issue 7332, pp. 124 - 129
Journal Article
Cancer Research, ISSN 0008-5472, 11/2001, Volume 61, Issue 22, pp. 8068 - 8073
Journal Article
Nature, ISSN 0028-0836, 03/2011, Volume 471, Issue 7339, pp. 467 - 472
Multiple myeloma is an incurable malignancy of plasma cells, and its pathogenesis is poorly understood. Here we report the massively parallel sequencing of 38... 
PATHOGENESIS | B-CELL LYMPHOMA | BLIMP-1 | GENE | MULTIDISCIPLINARY SCIENCES | STRESS-RESPONSE | EXOSOME | CLASSIFICATION | DIFFERENTIATION | HUMAN CANCER | SOMATIC MUTATIONS | Ribonucleases - genetics | Ribonucleases - chemistry | Genomics | Humans | Molecular Sequence Data | NF-kappa B - metabolism | DNA Repair - genetics | Multiple Myeloma - drug therapy | DNA Mutational Analysis | Protein Biosynthesis - genetics | Multiple Myeloma - enzymology | Proto-Oncogene Proteins B-raf - metabolism | Amino Acid Sequence | Oncogenes - genetics | Models, Molecular | Exons - genetics | Signal Transduction - genetics | Multiple Myeloma - metabolism | Mutation - genetics | Open Reading Frames - genetics | Genome, Human - genetics | Homeodomain Proteins - genetics | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | RNA Processing, Post-Transcriptional - genetics | Proto-Oncogene Proteins B-raf - genetics | CpG Islands - genetics | Blood Coagulation - genetics | Protein Conformation | Histones - metabolism | Transcription, Genetic - genetics | Exosome Multienzyme Ribonuclease Complex | Methylation | Homeostasis - genetics | Multiple Myeloma - genetics | Usage | Multiple myeloma | Development and progression | Genetic aspects | Research | Nucleotide sequencing | Methods | Cancer | Proteins | Pathogenesis | Homeostasis | Genetics | Genomes | Mutation | Kinases | Mass spectrometry | Index Medicus
Journal Article
Nature Immunology, ISSN 1529-2908, 12/2008, Volume 9, Issue 12, pp. 1364 - 1370
The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-kappa B (NF-kappa B) signaling in resting cells by... 
MULTIPLE-MYELOMA | CD40 | IMMUNE-SYSTEM | CRITICAL ROLES | KINASE | RECEPTOR | ALPHA | NF-KAPPA-B2 P100 | IMMUNOLOGY | TNF | CELL-DEATH
Journal Article
Blood, ISSN 0006-4971, 08/2018, Volume 132, Issue 6, pp. 554 - 555
An integrated genomic analysis presented by Walker et al in this issue of Blood confirms that the primary genetic event partially determines the pattern of... 
MULTIPLE-MYELOMA | HEMATOLOGY | Index Medicus | Abridged Index Medicus
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2016, Volume 22, Issue 7, pp. 706 - 707
Two recent studies provide novel insights into the mechanism of action of thalidomide analogs in multiple myeloma and del(5q) myelodysplastic syndrome. They... 
TARGET | MEDICINE, RESEARCH & EXPERIMENTAL | DEGRADATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL BIOLOGY | Thalidomide - analogs & derivatives | Humans | Molecular chaperones | Patient outcomes | Genetic aspects | Drug therapy | Thalidomide | Health aspects | Myelodysplastic syndromes | Studies | Calcium | Cancer | Tumors | Index Medicus
Journal Article